Adjunctive use of olanzapine in the treatment of mania
Peter Haddad, Imran B. Chaudhry, Som D. Soni
Abstract
Peter Haddad, Imran B. Chaudhry, Som D. Soni
Abstract
Olanzapine is an atypical antipsychotic which is licensed only for the treatment of schizophrenia. Two cases are described in which olanzapine was used (IS an adjunct to lithium in treating mania in patients with bipolar disorder. In both cases the lithium-olanzapine combination was more effective and better tolerated than a previous combination of lithium with a traditional antipsychotic. Olanzapine may offer significant advantages over traditional antipsychotics in the treatment of mania, but controlled trials are needed to confirm this.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Olanzapine is an atypical antipsychotic which is licensed only for the treatment of schizophrenia. Two cases are described in which olanzapine was used (IS an adjunct to lithium in treating mania in patients with bipolar disorder. In both cases the lithium-olanzapine combination was more effective and better tolerated than a previous combination of lithium with a traditional antipsychotic. Olanzapine may offer significant advantages over traditional antipsychotics in the treatment of mania, but controlled trials are needed to confirm this.
Key concepts: Olanzapine, Mania, Lithium (medication), Antipsychotic, Schizophrenia (object-oriented programming), Bipolar disorder, Psychiatry, Atypical antipsychotic